Aeluma, Inc. 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Market Information Our common stock trades on the OTCQB system under the symbol “ ALMU .” Our CUSIP number is 00776X. You should be aware that over-the-counter market quotations may reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not necessarily represent actual transactions. The high and low bid quotations for our shares of our common stock for each full quarterly period within the two most recent fiscal years are (prices set forth below represent inter-dealer quotations, without retail markup, markdown or commission and may not be reflective of actual transactions): High Low Fiscal 2022 Quarter ended September 30, 2021 $ N/A $ N/A Quarter ended December 31 2021 $ N/A $ N/A Quarter ended March 31, 2022 $ N/A $ N/A Quarter ended June 30, 2022 $ N/A $ N/A Fiscal 2021 Quarter ended September 30, 2020 $ N/A $ N/A Quarter ended December 31 2020 $ N/A $ N/A Quarter ended March 31, 2021 $ N/A $ N/A Quarter ended June 30, 2021 $ N/A $ N/A As of September 27, 2022, the last reported sale price of our Common Stock on the OTCQB was $N/A per share. As of September 27, 2022, we had 10,650,002 shares of our common stock outstanding held by approximately 87 stockholders of record. Dividend Policy We have never paid any cash dividends on our capital stock and do not anticipate paying any cash dividends on our common stock in the foreseeable future. We intend to retain future earnings to fund ongoing operations and future capital requirements. Any future determination to pay cash dividends will be at the discretion of our board of directors and will be dependent upon financial condition, results of operations, capital requirements and such other factors as the board of directors deems relevant. Recent Sales of Unregistered Securities During the period covered by this annual report, the Company has not issued unregistered securities to any person, except as described below. None of these transactions involved any underwriters, underwriting discounts or commissions, except as specified below, or any public offering, and, unless otherwise indicated below, the Registrant believes that each transaction was exempt from the registration requirements of the Securities Act by virtue of Section 4(a)(2) thereof and/or Rule 506 of Regulation D promulgated thereunder, and/or Regulation S promulgated thereunder regarding offshore offers and sales. All recipients had adequate access, though their relationships with the Registrant, to information about the Registrant. On July 1, 2021, we sold an additional 115,000 common stock shares at a purchase price of $2.00 per share in a private placement offering for net proceeds (after deducting offering costs of $23,070) of $206,930 and issued 11,500 warrants to purchase common stock to GP Nurmenkari Inc., who acted as the placement agent for this private placement offering. 6 Item 6. [Reserved].